Atlas Trials

Interest of Famotidine in Children With Sickle Cell Disease

Clinical trial NCT05084521 · COMPLETED

Trial details

NCT number
NCT05084521
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2022-01-12
Primary completion
2022-12-12
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.